Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults

August 21, 2024 updated by: University of Alberta
This project aims to address the impact of frailty on older adults, particularly its connection to cognitive impairments such as dementia. By identifying frailty in its early stages, interventions can be designed to slow down the progression of cognitive decline. To achieve this, the project plans to develop a reliable at-home monitoring system that can accurately track frailty in older adults with mild cognitive impairment or dementia. By utilizing cutting-edge technologies such as high-precision indoor positioning and home-installed sensors, referred to as zero-effort technologies (ZETs), the system will collect continuous sensor data, which will be analyzed to identify indicators of frailty.

Study Overview

Detailed Description

This project is centred around addressing the impact of frailty on older adults and its correlation with cognitive impairments, particularly dementia. The aim is to develop an effective and non-intrusive at-home monitoring system that can accurately track frailty in older adults with mild cognitive impairment or dementia. By identifying frailty in its early stages, interventions can be designed to slow down the progression of cognitive decline and improve the overall well-being of older adults.

To achieve this, the project plans to leverage cutting-edge technologies such as high-precision indoor positioning and home-installed sensors, collectively referred to as zero-effort technologies (ZETs). These technologies require minimal user effort and will provide a continuous stream of sensor data. The collected data will be systematically analyzed to identify indicators of frailty, allowing for early detection and intervention. Importantly, the project recognizes the significance of engaging older adults, caregivers, and healthcare professionals throughout the development process. Their attitudes, beliefs, and perceptions will be taken into consideration to ensure that the monitoring system is meaningful, beneficial, and respects user privacy.

By involving older adults and caregivers in the early stages, the project aims to create a monitoring system that can be seamlessly integrated into the lives of older adults dealing with frailty and cognitive impairments. The goal is to provide an affordable and efficient solution that can be implemented within the comfort and familiarity of their own homes. The continuous tracking of frailty data will enable healthcare professionals and caregivers to deliver timely interventions and support, thereby potentially slowing down the cognitive decline experienced by older adults.

Through the combination of advanced technologies and a user-centred approach, the project intends to bridge the gap between frailty and cognitive impairments in older adults. By identifying frailty at an early stage and tailoring interventions accordingly, personalized and targeted support can be provided to improve the quality of life for older adults with mild cognitive impairment or dementia. Ultimately, the project aims to contribute to the development of effective strategies for managing frailty and cognitive decline, benefiting both older adults and their caregivers, as well as clinicians.

Study Type

Observational

Enrollment (Actual)

21

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T5G 0B7
        • Glenrose Rehabilitation Hospital
      • Edmonton, Alberta, Canada, T5G2H6
        • Corbett Hall, University of Alberta

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Older aged adults (60+ years old), with or without frailty, and with or without mild cognitive impairment (MCI).

Description

Inclusion Criteria:

  • In-patients at the Glenrose Rehabilitation Hospital (GRH) and GRH' visitors or staff (e.g. patients' caregivers, relatives, friends of older adults in-patient or staff at the GRH who are interested in participating) who are 65 years old or older
  • For in-patients who are pre-frail or frail according to the scale used at the GRH (can be equivalent to Fried's scale pre-frail/frail (score = 1 - 4). For GRH's visitors or staff, are robust according to Fried's Frail Scale (score=0) as per the definition in (Fried, 2001)
  • With or without some level of cognitive impairment (Standardized mini-mental state examination (MMSE) of 21 to 30 ("mild" (24-21) to "could be normal" (25-30)) or the equivalent in the screening tool.
  • Have a cognitive ability to interact with the frailty sensors (i.e. scale, dynamometer, smart speaker).
  • Have a functional vision and hearing with or without aides (glasses/hearing aids) to be able to interact with furniture and sensors at the ILS and to fill out questionnaires.
  • Have functional upper extremity function to be able to interact with furniture and sensors at the ILS.
  • Be able to walk independently 15 meters with or without a walking aid.
  • If taking antidepressants or narcotics, participants have no changes in the medication for at least 3 months

Exclusion Criteria:

  • Those with a history of Parkinson's disease or other movement disorders or stroke.

Justification: Movement disorders causing tremors will affect data collection by the sensors

  • Those who were taking Sinemet or Aricept
  • Older adults who have Influenza, long Covid-19 or another virus that affect their performance
  • Unable to count, speak (name objects and say numbers) or comprehend simple instructions in English
  • Have severe cardiac or respiratory diseases that prevent them to perform vigorous activities
  • Using supplemental oxygen (i.e., must be able to breathe with room air)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Utilizing Smart Home Monitoring System in a Simulated Home Environment (in Hospital)
The project involves recruiting participants who will reside in a simulated condo environment within the Glenrose Rehabilitation Hospital. These participants will be remotely monitored using various sensors, including ones that track their interactions with appliances and furniture, smart biomechanics devices that assess their physical balance and strength, and a positioning system. By collecting and analyzing data from these sensors, the project aims to gain insights into the participants' daily activities, functional abilities, physical condition, and spatial behaviour.

During the study, various sensors will be employed to capture participant interactions with appliances and furniture. These sensors may include:

Interaction Sensors: These sensors are designed to recognize users' interactions with appliances and furniture within the smart environment.

Smart Biomechanics Devices: Devices such as a Fitbit device an internet of Things grip Dynamometer will be utilized to assess physical balance and strength.

Positioning System using Ultra-Wide Band (UWB) Technology: This positioning system leverages UWB technology, enabling furniture-level accuracies in interpreting self-care activities.

As participants engage with different elements of the smart environment, these sensors will collect data. Additionally, participants will be recorded via video to further enhance the observational data captured during the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Slowness (Mobility)
Time Frame: through study completion, within a total average of 2 hours
15 Foot Walk / 5 Metres, Timed. The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Weight (lbs, Kgs)
Time Frame: through study completion, within a total average of 2 hours
Weight taken using an internet of things scale
through study completion, within a total average of 2 hours
Exhaustion
Time Frame: through study completion, within a total average of 2 hours
Smart speaker delivered two questions from the Center for Epidemiological Studies-Depression (CES-D) scale (7. I felt that everything I did was an Effort, 20. I could not get "going."). The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Strength - Handgrip
Time Frame: through study completion, within a total average of 2 hours
Using a internet of things dynanometer, force will be assessed (3 times each hand - 30 seconds of rest between measurements) and to release it. The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Activity
Time Frame: through study completion, within a total average of 2 hours
The participant is asked to complete two tasks from the Performance Assessment of Self-Care Skills (PASS - Clinic) Version 4.1. This will involve a simulated version of carrying garbage, and sweeping the floors. The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Meal Preparation
Time Frame: through study completion, within a total average of 2 hours
Participants will be asked to prepare a simple sandwich using the kitchen elements.The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Observe Free Activity
Time Frame: through study completion, within a total average of 2 hours
During the data collection, participants will be given 5 minutes to do whatever activity they want. The sensors and the camera will record the participants' data during this time.
through study completion, within a total average of 2 hours
Qualitative Interviews Regarding Technology
Time Frame: Through study completion, within a total average of 2 hours
Qualitative Interview (Based on the Unified Theory of Acceptance and Use of Technology (UTAUT) constructs)
Through study completion, within a total average of 2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jim Raso, MASc, Alberta Health Services

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2023

Primary Completion (Actual)

March 20, 2024

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

June 26, 2023

First Submitted That Met QC Criteria

July 17, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

August 23, 2024

Last Update Submitted That Met QC Criteria

August 21, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00131722

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe